Current devices for high-performance whole-body hyperthermia therapy

References

• Takano YS, Harmon BV, Kerr JF. Apoptosis induced by mild hyperthermia in human and murine tumour cell lines: a study using electron microscopy and DNA gel electrophoresis. J. Pathol.163(4), 329–336 (1991).
   PubMed Web of Science ®Google Scholar
• Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of “heat-controlled necrosis” with heat shock protein expression. Cancer Immunol. Immunother.55(3), 320–328 (2006).
   PubMed Web of Science ®Google Scholar
• Siddiqui F, Avery PR, Li CY et al. Induction of the human heat shock promoter HSP 70b by nutritional stress: implications for cancer gene therapy. Cancer Invest.26(6), 553–561 (2008).
   PubMed Web of Science ®Google Scholar
• Siddiqui F, Kolozsvary A, Barton KN, Freytag SO, Brown SL, Kim JH. Does hyperthermia increase adenoviral transgene expression or dissemination in tumors? Int. J. Hyperthermia25(4), 273–279 (2009).
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int. J. Hyperthermia23(5), 431–442 (2007).
   PubMed Web of Science ®Google Scholar
• Tarner IH, Müller-Ladner U, Uhlemann C, Lange U. The effect of mild whole-body hyperthermia on systemic levels of TNF-α, IL-1β, and IL-6 in patients with ankylosing spondylitis. Clin. Rheumatol.28(4), 397–402 (2009).
   PubMed Web of Science ®Google Scholar
• Franckena M, Stalpers LJ, Koper PCM et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int. J. Radiat. Oncol. Biol. Phys.70(4), 1176–1182 (2008).
   PubMed Web of Science ®Google Scholar
• Sreedhar AS, Csermely P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol. Ther.101(3), 227–257 (2004).
   PubMed Web of Science ®Google Scholar
• Multhoff G. Activation of natural killer cells by heat shock protein 70. Int. J. Hyperthermia25(3), 169–175 (2009).
   PubMed Web of Science ®Google Scholar
• Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer3(6), 401–410 (2003).
   PubMed Web of Science ®Google Scholar
• Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol.40(10), 2353–2362 (1990).
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol.43(1), 33–56 (2002).
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G et al. Hyperthermia in combined treatment of cancer. Lancet Oncol.3(8), 487–497 (2002).
   PubMed Web of Science ®Google Scholar
• Van der Zee J, Gonzalez D, van Rhoon GC, van Dijk JDP, van Putten WLJ, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet355(9210), 1119–1125 (2000).
   PubMed Web of Science ®Google Scholar
• Kraybill WG, Olenki T, Evans SS et al. A Phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models. Int. J. Hyperthermia18(3), 253–266 (2002).
   PubMed Web of Science ®Google Scholar
• Atanackovic D, Pollok K, Faltz C et al. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory t-cell subtypes. Am. J. Physiol. Regul. Integr. Comp. Physiol.290(3), R585–R594 (2006).
   PubMed Web of Science ®Google Scholar
• Milani V, Lorenz M, Weinkauf M et al. Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells. Int. J. Hyperthermia25(4), 262–272 (2009).
   PubMed Web of Science ®Google Scholar
• Bakhshandeh A, Bruns I, Traynor A et al. Ifosfamide, carboplatin and etoposide combined with 41.8°C whole body hyperthermia for malignant pleural mesothelioma. Lung Cancer39(3), 339–345 (2003).
   PubMedGoogle Scholar
• Wiedemann GJ, d‘Oleire F, Knop E et al. Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res.54(20), 5346–5350 (1994).
   PubMedGoogle Scholar
• Lohmann R. Pilot study of whole-body hyperthermia combined with chemotherapy in patients with metastasised pretreated progressive breast, ovarian, and colorectal carcinomas. Tumordiagn. U. Ther.22, 115–120 (2001).
   Google Scholar
• Park MY, Jung SE, Cho SH et al. Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer. Int. J. Hyperthermia25(3), 180–188 (2009).
   PubMed Web of Science ®Google Scholar
• Strobl B, Rjosk D, Janni W et al. Whole body hyperthermia combined with carboplatin/paclitaxel in patients with ovarian carcinoma – Phase-II-study. J. Clin. Oncol.22(14 Suppl.), 5128–5129 (2004).
   Google Scholar
• Atmaca A, Al-Batran SE, Neumann A et al. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a Phase II study. Gynecol. Oncol.112(2), 384–388 (2009).
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Dräger J, Kerner T et al. Whole-body hyperthermia in the scope of Von Ardenne‘s systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a Phase I/II study. Int. J. Hyperthermia20(3), 317–333 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Arya M, Levitt G, Duffy PG, Sebire NJ, Mushtaq I. Part II: treatment of primary malignant non-wilms’ renal tumours in children. Lancet Oncol.8(9), 842–848 (2007).
   PubMedGoogle Scholar
• Richel O, Zum Vörde Sive Vörding PJ, Rietbroek R et al. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer. Gynecol. Oncol.95(3), 680–685 (2004).
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int. J. Hyperthermia25(5), 338–343 (2009).
   PubMed Web of Science ®Google Scholar
• Bergs JW, Franken NAP, Haveman J, Geijsen ED, Crezee J, Van Bree C. Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment: a review from preclinical studies to clinical application. Int. J. Hyperthermia23(4), 329–341 (2007).
   PubMed Web of Science ®Google Scholar
• Yu D-Y, Zhao Q-L, Wei Z-L, Shehata M, Kondo T. Enhancement of hyperthermia-induced apoptosis by sanazole in human lymphoma u937 cells. Int. J. Hyperthermia25(5), 364–373 (2009).
   PubMed Web of Science ®Google Scholar
• Sheeja K, Kuttan G. Effect of Andrographis paniculata as an adjuvant in combined chemo-radio and whole body hyperthermia treatment – a preliminary study. Immunopharmacol. Immunotoxicol.30(1), 181–194 (2008).
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Hegewisch-Becker S, Kerner T et al. Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. Int. J. Hyperthermia21(2), 169–183 (2005).
   PubMed Web of Science ®Google Scholar
• Xiang S-H, Chen B-W, Zhou Y-X, Yan X-M, Liu J. Development of interventional whole body hyperthermia system: part I: device fabrication and performance evaluation. Forschung im Ingenieurwesen72(3), 145–152 (2008).
   Google Scholar
• Kinsht NV, Kinsht DN. Mathematical modelling of systemic circulation and heat exchange in whole body hyperthermia (43–44 c). In: Proceeding (483) ACIT – Automation, Control, and Applications – 2005. Shokin YI, Potaturkin OI (Eds). ACTA Press, Novosibirsk, Russia, 20–23 (2005).
   Google Scholar
• Xiang S, Liu J. Comprehensive evaluation on the heating capacities of four typical whole body hyperthermia strategies via compartmental model. Int. J. Heat Mass Trans.51(23–24), 5486–5496 (2008).
   Web of Science ®Google Scholar
• Von Ardenne M, Kirsch R. On the methodology of extreme hyperthermia, with special reference to multi-step cancer chemotherapy. Dtsch. Gesundheitsw.20(43), 1935–1940 (1965).
   PubMedGoogle Scholar
• Kirsch E, Von Ardenne M, Reitnauer PG. [A recently developed vibrating chair and its significance in the conservative treatment of urolithiasis. Concluding remarks]. Z. Urol. Nephrol.58(4), 225–236 (1965).
   PubMedGoogle Scholar
• Kirsch R, Schmidt D. Klinische und experimentelle erfahrungen mit der mehrschritt-therapie. Zentralblatt für Chirurgie36, 1297–1312 (1966).
   Google Scholar
• Law HT, Pettigrew RT. Whole-body and regional hyperthermia by direct heating. In: Hyperthermia. Blackie, Glasgow, UK 180–201 (1986).
   Google Scholar
• Von Ardenne M, Von Ardenne T, Böhme G, Reitnauer PG. [Selective local hyperthermy of tumor tissue. Homogenized energy supply also to deep-seated tissues by high-performance decametric wave coil section plus dual system raster motion (author transl.)]. Arch. Geschwulstforsch.47(6), 487–523 (1977).
   PubMedGoogle Scholar
• Park WY, Macnamara TE. Temperature change and neuromuscular blockade by d-tubocurarine or pancuronium in man. Anesthesiology50(2), 161–163 (1979).
   PubMedGoogle Scholar
• Parks LC, Minaberry D, Smith DP, Neely WA. Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. J. Thorac. Cardiovasc. Surg.78(6), 883–892 (1979).
   PubMed Web of Science ®Google Scholar
• Maeta M, Koga S, Shimizu N et al. Effect of extracorporeally induced total body hyperthermia for cancer on cardiovascular function. Jpn. Heart J.25(6), 993–1000 (1984).
   PubMedGoogle Scholar
• Willnow U, Lindner H, Brock D et al. [Treatment of otherwise incurable tumor diseases in childhood using whole-body hyperthermia and chemotherapy]. Dtsch. Med. Wochenschr.114(6), 208–213 (1989).
   PubMedGoogle Scholar
• Edelmann A, Mahanna DL, Lewis LA, Thatcher JS, Hartman FA. The use of adrenal extract in fever therapy. J. Clin. Endocrinol. Metab.3(1), 20 (1943).
   Google Scholar
• Robins HI, Dennis WH, Neville AJ et al. A nontoxic system for 41.8°C whole-body hyperthermia: results of a Phase I study using a radiant heat device. Cancer Res.45(8), 3937–3944 (1985).
   PubMed Web of Science ®Google Scholar
• Robins HI, Longo W. Whole body hyperthermia: simple complexities. Intensive Care Med.25(9), 898–900 (1999).
   PubMedGoogle Scholar
• Heckel M, Heckel I. [Studies on 479 cases of infrared hyperthermia treatments. Contribution to the method of whole body hyperthermia]. Med. Welt30(25), 971–975 (1979).
   PubMedGoogle Scholar
• Wust P, Riess H, Hildebrandt B et al. Feasibility and analysis of thermal parameters for the whole-bodyhyperthermia system iratherm-2000. Int. J. Hyperthermia16(4), 325–339 (2000).
   PubMed Web of Science ®Google Scholar
• Wust P, Gneveckow U, Johannsen M et al. Magnetic nanoparticles for interstitial thermotherapy: feasibility, tolerance and achieved temperatures. Int. J. Hyperthermia22(8), 673–685 (2006).
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Taymoorian K et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective Phase I trial. Int. J. Hyperthermia23(3), 315–323 (2007).
   PubMed Web of Science ®Google Scholar
• Sharma R, Chen CJ. Newer nanoparticles in hyperthermia treatment and thermometry. J. Nanopart. Res.11(3), 671–689 (2009).
   Web of Science ®Google Scholar
• Foster KR, Glaser R. Thermal mechanisms of interaction of radiofrequency energy with biological systems with relevance to exposure guidelines. Health Phys.92(6), 609–620 (2007).
   PubMed Web of Science ®Google Scholar
• Nittby H, Grafstr MG, Eberhardt JL et al. Radiofrequency and extremely low-frequency electromagnetic field effects on the blood-brain barrier. Electromagn. Biol. Med.27(2), 103–126 (2008).
   PubMed Web of Science ®Google Scholar
• Dahl O. Status of clinical hyperthermia. Acta Oncol.38(7), 863–873 (1999).
   PubMed Web of Science ®Google Scholar
• Nikiforov V. Magnetic induction hyperthermia. Russ. Phys. J.50(9), 913–924 (2007).
   Google Scholar
• Roszkowski W, Wrembel JM, Roszkowski K, Janiak M, Szmigielski S. Effect of whole-body microwave hyperthermia on delayed cutaneous hypersensitivity in tumor-bearing mice. J. Cancer Res. Clin. Oncol.97(1), 23–29 (1980).
   PubMed Web of Science ®Google Scholar
• Hauck ML, LaRue SM, Petros WP et al. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin. Cancer Res.12(13), 4004–4010 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson DA, Charbonnel S, Curran AR et al. A high-resolution voxel model for predicting local tissue temperatures in humans subjected to warm and hot environments. J. Biomech. Eng.131, 041003 (2009).
   Google Scholar
• Chen XL, Wang F, Bao YQ. An accidental burn resulted from whole body hyperthermia therapy. Burns33(2), 252–254 (2007).
   PubMedGoogle Scholar
• Kokura S, Adachi S, Manabe E et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int. J. Hyperthermia23(3), 259–265 (2007).
   PubMed Web of Science ®Google Scholar
• Dong J, Shi-ying Z, Suo-Cheng C. Research progress of whole body hyperthermia and apoptosis of tumor cells. Medical Recapitulate14(1), 50–53 (2008).
   Google Scholar
• Hager ED, Dziambor H, Hohmann D, Muhe N, Strama H. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer. Int. J. Gynecol. Cancer11(Suppl. 1), 57–63 (2001).
   PubMedGoogle Scholar
• Douwes F, Bogovic J, Douwes O, Migeod F, Grote C. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. Int. J. Clin. Oncol.9(2), 85–91 (2004).
   PubMedGoogle Scholar
• Alvarez Secord A, Jones EL, Hahn CA et al. Phase I/II trial of intravenous doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. Int. J. Hyperthermia21(4), 333–347 (2005).
   PubMed Web of Science ®Google Scholar
• Von Ardenne A, Wehner H. Extreme whole-body hyperthermia with water-filtered infrared-a radiation. In: Hyperthermia in Cancer Treatment: A Primer. Baronzio GF, Hager ED (Eds). Springer Science, NY, USA, 237 (2006).
   Google Scholar
• Brockow T, Wagner A, Franke A, Offenbächer M, Resch KL. A randomized controlled trial on the effectiveness of mild water-filtered near infrared whole-body hyperthermia as an adjunct to a standard multimodal rehabilitation in the treatment of fibromyalgia. Clin. J. Pain23(1), 67–75 (2007).
   PubMed Web of Science ®Google Scholar
• Kerner T, Hildebrandt B, Ahlers O et al. Anaesthesiological experiences with whole body hyperthermia. Int. J. Hyperthermia19(1), 1–12 (2003).
   PubMed Web of Science ®Google Scholar
• Schencking M, Frese T, Sandholzer H. [Treatment of a radiculopathia by whole-body hyperthermia]. Forsch Komplementmed.15(5), 273 (2008).
   PubMedGoogle Scholar
• Yang W, Fu W, Li X et al. Clinical application of whole body hyperthermia to treat advaced carcinoma. Journal of North China Coal Medical College6(4), 688–690 (2002).
   Google Scholar
• Liu Y, Ding X, Liu P, Yang Y, Pan X. Case report of whole body hyperthermia to treat bone metastasis of thyroid carcinoma. Journal of Shandong University (Health Sciences)45(9), 968–969 (2007).
   Google Scholar
• Ahlers O, Hildebrandt B, Dieing A et al. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8–42.2°C. Eur. J. Appl. Physiol.95(4), 298–306 (2005).
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Schoeler D, Ringel F et al. Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: a pilot study. Int. J. Hyperthermia22(8), 625–635 (2006).
   PubMed Web of Science ®Google Scholar
• Wehner H, Von Ardenne A, Kaltofen S. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences. Int. J. Hyperthermia17(1), 19–30 (2001).
   PubMed Web of Science ®Google Scholar
• Ohishi T, Nukuzuma C, Seki A et al. Alkalization of blood ph is responsible for survival of cancer patients by mild hyperthermia. Biomed. Res.30(2), 95 (2009).
   PubMedGoogle Scholar
• Bull JMC, Scott GL, Strebel FR et al. Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-α: a description of a Phase I-II protocol. Int. J. Hyperthermia24(8), 649–662 (2008).
   PubMed Web of Science ®Google Scholar
• Wrzal PK, Bettaieb A, Averill-Bates DA. Molecular mechanisms of apoptosis activation by heat shock in multidrug-resistant chinese hamster cells. Radiat. Res.170(4), 498–511 (2008).
   PubMedGoogle Scholar
• Sumiyoshi K, Strebel FR, Rowe RW, Bull JMC. The effect of whole-body hyperthermia combined with ‘metronomic’ chemotherapy on rat mammary adenocarcinoma metastases. Int. J. Hyperthermia19(2), 103–118 (2003).
   PubMed Web of Science ®Google Scholar
• Pritchard MT, Ostberg JR, Evans SS et al. Protocols for simulating the thermal component of fever: preclinical and clinical experience. Methods32(1), 54–62 (2004).
   PubMed Web of Science ®Google Scholar
• Pritchard MT, Wolf SF, Kraybill WF, Repasky EA. The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy. Immunol. Invest.34(3), 361–380 (2005).
   PubMed Web of Science ®Google Scholar
• Ishibashi J, Yamashita K, Ishikawa T et al. The effects inhibiting the proliferation of cancer cells by far-infrared radiation (FIR) are controlled by the basal expression level of heat shock protein (HSP) 70a. Med. Oncol.25(2), 229–237 (2008).
   PubMedGoogle Scholar
• Hattori T, Kokura S, Okuda T et al. Antitumor effect of whole body hyperthermia with α-galactosylceramide in a subcutaneous tumor model of colon cancer. Int. J. Hyperthermia23(7), 591–598 (2007).
   PubMed Web of Science ®Google Scholar
• Toyokawa H, Matsui Y, Uhara J et al. Promotive effects of far-infrared ray on full-thickness skin wound healing in rats. Exp. Biol. Med. (Maywood)228(6), 724–729 (2003).
   PubMed Web of Science ®Google Scholar
• Yamada Y, Itoh Y, Aoki S et al. Preliminary results of m-vac chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium. Cancer Chemother. Pharmacol.64(6), 1079–1083 (2009).
   PubMedGoogle Scholar
• Witkamp AJ, De Bree E, Kaag MM et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-c in patients with peritoneal carcinomatosis of colorectal origin. Eur. J. Cancer37(8), 979–984 (2001).
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat. Rev.27(6), 365–374 (2001).
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, De Bree E, Kaag MM, Van Slooten GW, Van Coevorden F, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br. J. Surg.88(3), 458–463 (2001).
   PubMed Web of Science ®Google Scholar
• Matsuzaki Y, Edagawa M, Shimizu T et al. Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis. Ann. Thorac. Surg.78(5), 1769–1772 (2004).
   PubMedGoogle Scholar
• Zwischenberger JB, Vertrees RA, Woodson LC et al. Percutaneous venovenous perfusion-induced systemic hyperthermia for advanced non-small cell lung cancer: initial clinical experience. Ann. Thorac. Surg.72(1), 234–242 (2001).
   PubMedGoogle Scholar
• Vertrees RA, Leeth A, Girouard M, Roach JD, Zwischenberger JB. Whole-body hyperthermia: a review of theory, design and application. Perfusion17(4), 279–290 (2002).
   PubMed Web of Science ®Google Scholar
• Zwischenberger JB, Vertrees RA, Bedell EA, McQuitty CK, Chernin JM, Woodson LC. Percutaneous venovenous perfusion-induced systemic hyperthermia for lung cancer: a Phase I safety study. Ann. Thorac. Surg.77(6), 1916–1925 (2004).
   PubMedGoogle Scholar
• Vertrees RA, Das GC, Coscio AM, Xie J, Zwischenberger JB, Boor PJ. A mechanism of hyperthermia-induced apoptosis in ras-transformed lung cells. Mol. Carcinog.44(2), 111–121 (2005).
   PubMed Web of Science ®Google Scholar
• Vertrees RA, Das GC, Popov VL et al. Synergistic interaction of hyperthermia and gemcitabine in lung cancer. Cancer Biol. Ther.4(10), 1144–1153 (2005).
   PubMed Web of Science ®Google Scholar
• Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J. Am. Coll. Surg.208(5), 931–937 (2009).
   PubMed Web of Science ®Google Scholar
• Xiang S-H, Chen B-W, He X-H et al. Development of interventional whole body hyperthermia system: part II: in vivo animal experimental evaluation. Forschung im Ingenieurwesen73(3), 139–146 (2009).
   Google Scholar
• Xiang S-H, Liu J, Zhou Y-X, Yan X-M. Monitoring temperature of a heating needle and surrounding blood during interventional whole body hyperthermia therapy. Meas. Sci. Tech.18(11), 3417–3424 (2007).
   Google Scholar
• Malyutina YV, Makarova YM, Semenets TN, Semina OV, Mosin AF, Kabakov AE. Whole body hyperthermia in mice confers heat shock protein-dependent radioresistance of their bone marrow and thymocytes. J. Therm. Biol.30(7), 511–517 (2005).
   Google Scholar
• Tolson JK, Roberts SM. Manipulating heat shock protein expression in laboratory animals. Methods35(2), 149–157 (2005).
   PubMed Web of Science ®Google Scholar
• Chankova SG, Yurina NP, Dimova EG et al. Pretreatment with heat does not affect double-strand breaks DNA rejoining in Chlamydomonas reinhardtii. J. Therm. Biol.34(7), 332–336 (2009).
   Google Scholar
• Zaidi AK, Patil MS, Bagewadikar RS, Subramanian M, Kaklij GS. Radioprotection by whole body hyperthermia: possible mechanism(s). J. Therm. Biol.27(1), 29–37 (2002).
   Google Scholar
• Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol. Ther.111(1), 194–223 (2006).
   PubMed Web of Science ®Google Scholar
• Nyberg F, Hallberg M, Hari Shanker S. Neuropeptides in hyperthermia. In: Progress in Brain Research. Elsevier, MO, USA, 277–293 (2007).
   Google Scholar
• Vinkers CH, Van Bogaert MJ, Klanker M et al. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (sih) paradigm. Eur. J. Pharmacol.585(2–3), 407–425 (2008).
   PubMed Web of Science ®Google Scholar
• Szelényi Z. Cholecystokinin: role in thermoregulation and other aspects of energetics. Clin. Chim. Acta411(5–6), 329–335 (2009).
   PubMedGoogle Scholar
• Dhiraj A, Daniel C, Trent P, Mikhail S, Robert BR. Direct thermal dose control of constrained focused ultrasound treatments: phantom and in vivo evaluation. Phys. Med. Biol.50(8), 1919–1935 (2005).
   PubMedGoogle Scholar
• Arora D, Skliar M, Cooley D, Blankespoor A, Moellmer J, Roemer R. Nonlinear model predictive thermal dose control of thermal therapies: experimental validation with phantoms. In: American Control Conference, 2004. Proceedings of the 2004 American Control Conference. AAC (Eds). IEEE, Boston, MA, USA, 1627–1632 (2004).
   Google Scholar
• Hjertaker BT, Froystein T, Schem BC. A thermometry system for quality assurance and documentation of whole body hyperthermia procedures. Int. J. Hyperthermia21(1), 45–55 (2005).
   PubMed Web of Science ®Google Scholar
• Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: invasive, minimal-invasive and non-invasive approaches. Int. J. Hyperthermia22(3), 255–262 (2006).
   PubMed Web of Science ®Google Scholar
• Sikoski P, Banks ML, Gould R, Young RW, Wallace JM, Nader MA. Comparison of rectal and infrared thermometry for obtaining body temperature in cynomolgus macaques (Macaca fascicularis). J. Med. Primatol.36(6), 381–384 (2007).
   PubMedGoogle Scholar
• Kistemaker JA, Den Hartog EA, Daanen HA. Reliability of an infrared forehead skin thermometer for core temperature measurements. J. Med. Eng. Technol.30(4), 252–261 (2006).
   PubMedGoogle Scholar
• Zhang S, Malloy CR, Sherry AD. MRI thermometry based on paracest agents. J. Am. Chem. Soc.127(50), 17572 (2005).
   PubMed Web of Science ®Google Scholar
• Vanne A, Hynynen K. MRI feedback temperature control for focused ultrasound surgery. Phys. Med. Biol.48(1), 31–43 (2003).
   PubMed Web of Science ®Google Scholar
• Wyatt C, Soher B, Maccarini P, Charles HC, Stauffer P, Macfall J. Hyperthermia mri temperature measurement: evaluation of measurement stabilisation strategies for extremity and breast tumours. Int. J. Hyperthermia25(6), 422–433 (2009).
   PubMed Web of Science ®Google Scholar
• Mirko W, Peter W, Martin W et al. Adaptation of antenna profiles for control of mr guided hyperthermia (HR) in a hybrid MR–HT system. Med. Phys.34(12), 4717–4725 (2007).
   PubMedGoogle Scholar
• Bayford RH. Bioimpedance tomography (electrical impedance tomography). Annu. Rev. Biomed. Eng.8(1), 63–91 (2006).
   PubMed Web of Science ®Google Scholar
• Meaney PM, Paulsen KD, Fanning MW, Li D, Fang Q. Image accuracy improvements in microwave tomographic thermometry: phantom experience. Int. J. Hyperthermia19(5), 534–550 (2003).
   PubMed Web of Science ®Google Scholar
• Xia Y, Hu Z, Nan Q, Jia L, Peng J, Zeng Y. Design of double ultrasound pulse transmission and receiving circuit used in ultrasound thermometry. J. Med. Eng. Tech.30(2), 112–118 (2006).
   Google Scholar
• Kamiyama T, Ito J, Noda H, Iwasa H, Kiyanagi Y, Ikeda S. Computer tomography thermometry – an application of neutron resonance absorption spectroscopy. Nucl. Instrum. Meth. Phys. Res.A542(1–3), 258–263 (2005).
   Google Scholar
• Han B, Hanson W, Bensalah K, Tuncel A, Stern J, Cadeddu J. Development of quantum dot-mediated fluorescence thermometry for thermal therapies. Ann. Biomed. Eng.37(6), 1230–1239 (2009).
   PubMed Web of Science ®Google Scholar
• Szasz A, Szasz O, Szasz N. Electro-hyperthermia: a new paradigm in cancer therapy. DZO33(3), 91–99 (2001).
   Google Scholar
• Fiorentini G, Szasz A. Hyperthermia today: electric energy, a new opportunity in cancer treatment. J. Cancer Res. Ther.2(2), 41–46 (2006).
   PubMedGoogle Scholar
• Andocs G, Szasz O, Szasz A. Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn. Biol. Med.28(2), 148–165 (2009).
   PubMed Web of Science ®Google Scholar
• Andocs G, Renner H, Balogh L, Fonyad L, Jakab C, Szasz A. Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther. Onkol.185(2), 120–126 (2009).
   PubMed Web of Science ®Google Scholar
• Kennedy JE. Innovation: high-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer5(4), 321–327 (2005).
   PubMed Web of Science ®Google Scholar
• Wootton JH, Ross AB, Diederich CJ. Prostate thermal therapy with high intensity transurethral ultrasound: the impact of pelvic bone heating on treatment delivery. Int. J. Hyperthermia23(8), 609–622 (2007).
   PubMed Web of Science ®Google Scholar
• Burtnyk M, Chopra R, Bronskill MJ. Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations. Int. J. Hyperthermia25(2), 116–131 (2009).
   PubMed Web of Science ®Google Scholar
• Puccini S, Bar NK, Bublat M, Kahn T, Busse H. Simulations of thermal tissue coagulation and their value for the planning and monitoring of laser-induced interstitial thermotherapy (LITT). Magn. Res. Med.49(2), 351–362 (2003).
   PubMed Web of Science ®Google Scholar
• Vesselov LM, Whittington W, Lilge L. Performance evaluation of cylindrical fiber optic light diffusers for biomedical applications. Lasers Surg. Med.34(4), 348–351 (2004).
   PubMed Web of Science ®Google Scholar
• Ma N, Gao X, Zhang XX. Two-layer simulation model of laser-induced interstitial thermo-therapy. Lasers Med. Sci.18(4), 184–189 (2004).
   PubMedGoogle Scholar
• Zhou J, Liu J. Numerical study on 3-D light and heat transport in biological tissues embedded with large blood vessels during laser-induced thermotherapy. Numerical Heat Transfer: Part A – Applications45(5), 415–449 (2004).
   Web of Science ®Google Scholar
• Zhou J, Zhang Y, Chen J. Effects of large blood vessels on the transient propagation of ultrafast laser pulse in biological tissues. Heat Mass Trans.45(5), 527–535 (2009).
   Google Scholar
• Atsarkin VA, Levkin LV, Posvyanskiy VS et al. Solution to the bioheat equation for hyperthermia with La1xAgyMnO3 nanoparticles: the effect of temperature autostabilization. Int. J. Hyperthermia25(3), 240–247 (2009).
   PubMed Web of Science ®Google Scholar
• Li F-R, Yan W-H, Guo Y-H, Qi H, Zhou H-X. Preparation of carboplatin-fec-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer. Int. J. Hyperthermia25(5), 383–391 (2009).
   PubMed Web of Science ®Google Scholar
• Renard P-EL, Buchegger F, Petri-Fink A et al. Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Int. J. Hyperthermia25(3), 229–239 (2009).
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma R, Zhu L. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern. Int. J. Hyperthermia25(4), 309–321 (2009).
   PubMed Web of Science ®Google Scholar
• Babincova M, Sourivong P, Leszczynska D, Babinec P. Blood-specific whole-body electromagnetic hyperthermia. Med. Hypotheses55(6), 459–460 (2000).
   PubMed Web of Science ®Google Scholar
• Babincova M, Altanerova V, Altaner C, Cicmanec P, Babinec P. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med. Phys.31(8), 2219–2221 (2004).
   PubMed Web of Science ®Google Scholar
• Sreenivasa G, Gellermann J, Rau B et al. Clinical use of the hyperthermia treatment planning system hyperplan to predict effectiveness and toxicity. Int. J. Radiat. Oncol. Biol. Phys.55(2), 407–419 (2003).
   PubMed Web of Science ®Google Scholar
• Bakshandeh A, Bruns I, Eberhardt K et al. Ifosfamide, carboplatin and etoposide combined with aquatherm-induced 41.8 °C whole-body hyperthermia for adult patients with malignant pleural mesothelioma. Ann. Oncol.11(4), 113–115 (2000).
   Google Scholar
• Westermann AM, Wiedemann GJ, Jager E et al. A systemic hyperthermia oncologic working group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8°C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology64(4), 312–321 (2003).
   PubMed Web of Science ®Google Scholar
• Dieing A, Ahlers O, Kerner T et al. Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology207(4), 265–273 (2003).
   PubMed Web of Science ®Google Scholar
• Gong B, Asimakis GK, Chen Z et al. Whole-body hyperthermia induces up-regulation of vascular endothelial growth factor accompanied by neovascularization in cardiac tissue. Life Sci.79(19), 1781–1788 (2006).
   PubMed Web of Science ®Google Scholar
• Chen M-Y, Lin J-H, Tai D-Y et al. Alteration of arterial blood pressure and myocardial injury induced by whole body hyperthermia in pigs. J. Mol. Cell. Cardiol.40(6), 1009 (2006).
   Google Scholar
• Lagendijk JJW. Hyperthermia treatment planning. Phys. Med. Biol.(5), R61 (2000).
   Google Scholar
• Gellermann J, Wust P, Stalling D et al. Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. Int. J. Radiat. Oncol. Biol. Phys.47(4), 1145–1156 (2000).
   PubMed Web of Science ®Google Scholar